This article reports on the pressing issue of underdiagnosed chronic kidney disease (CKD) in Germany, emphasizing the need for proactive screening and early intervention. Despite the availability of simple, cost-effective tests, CKD often goes undetected until its later stages, leading to serious health consequences.
In Germany, over 10 million people live with CKD, with a staggering three out of four unaware of their condition. This lack of awareness is attributed to the asymptomatic nature of CKD until significant kidney function loss has occurred.
The article highlights the findings of the InspeCKD study, revealing a concerningly low rate of eGFR and urine albumin testing among high-risk patients. This lack of testing persists despite the known effectiveness of these tests in identifying individuals at risk of CKD progression.
Early diagnosis and treatment are paramount in managing CKD and improving patient outcomes. Effective medications exist that can slow or even halt CKD progression, particularly in its early stages.
The article discusses promising new medications for CKD, including SGLT-2 inhibitors, the mineralocorticoid receptor antagonist finerenone, and glucagon-like peptide 1 receptor agonists. These medications offer new avenues for slowing kidney function decline and improving patient prognosis.
The German Society of Nephrology (DGfN) advocates for the inclusion of CKD screening in the Healthy Heart Act (GHG) to promote early detection and reduce the burden of cardiovascular disease, a common comorbidity of CKD. The DGfN also calls for fundamental CKD screening to be integrated into health examinations covered by statutory health insurance from the age of 35.
The article underscores the urgent need for increased awareness, proactive screening, and timely intervention in CKD. By addressing this silent epidemic head-on, healthcare professionals can significantly improve patient outcomes and reduce the burden of this serious public health concern.
他の言語に翻訳
原文コンテンツから
www.medscape.com
抽出されたキーインサイト
by Ute Eppinger 場所 www.medscape.com 10-08-2024
https://www.medscape.com/viewarticle/nephrologists-urge-active-search-chronic-kidney-disease-2024a1000icc深掘り質問